Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 30 min 26 sec ago

FDA Approves VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older

Mon, 10/13/2014 - 13:13
SARATOGA, Calif., Oct. 13, 2014 -- (Healthcare Sales & Marketing Network) -- VisionCare Ophthalmic Technologies, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), ...
Devices, Ophthalmology, FDA
VisionCare Ophthalmic Technologies, telescope implant, macular degeneration

FDA Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)

Mon, 10/13/2014 - 13:08
First New Fixed Combination Targeting Two Critical Pathways Involved in CINV LUGANO, Switzerland and WOODCLIFF LAKE, N.J., Oct. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Helsinn Group and Eisai Inc. announced today that the Food and Drug Ad...
Biopharmaceuticals, FDA
Eisai, Helsinn Group, AKYNZEO, CINV

VEXIM to Initiate Clinical Study to Support Planned 510(k) Application to Market SpineJack(R) in the United States

Mon, 10/13/2014 - 12:56
Safety and effectiveness of SpineJack® will be compared with balloon kyphoplasty in 150 patients in Europe TOULOUSE, France--(Healthcare Sales & Marketing Network)--VEXIM (ALVXM.PA) (FR0011072602 – ALVXM / Eligible PEA-PME), a medical device company...
Devices, Neurosurgery, Orthopaedic
VEXIM , SpineJack, vertebroplasty, kyphoplasty

Regado Biosciences Appoints Michael A. Metzger CEO

Fri, 10/10/2014 - 13:30
BASKING RIDGE, N.J., Oct. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Regado Biosciences, Inc. (RGDO), today announced the appointment of Michael A. Metzger, president of Regado, to the additional post of chief executive officer and as a member ...
Biopharmaceuticals, Personnel
Regado Biosciences, Revolixys

Aymeric Le Chatelier joins Ipsen as Executive Vice President, Chief Financial Officer

Fri, 10/10/2014 - 13:21
PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Aymeric Le Chatelier as Executive Vice President, Chief Financial Officer effective as of 3 November 2014. He will report directly to Marc d...
Biopharmaceuticals, Personnel
Ipsen

Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs

Fri, 10/10/2014 - 13:11
WINNERSH, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Me...
Biopharmaceuticals, Personnel
Vernalis

Angiotech Appoints John Barr as CEO

Thu, 10/09/2014 - 13:39
VANCOUVER, Oct. 9, 2014 -- (Healthcare Sales & Marketing Network) - Angiotech Pharmaceuticals, Inc. announced today that its Board of Directors has appointed John R. Barr as Chief Executive Officer. Mr. Barr brings over 35 years of medical device and oper...
Biopharmaceuticals, Personnel
Angiotech Pharmaceuticals

Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve

Thu, 10/09/2014 - 13:37
VANCOUVER , Oct. 9, 2014 (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. F...
Devices, Interventional Cardiology, FDA
Neovasc, Tiara, transcatheter mitral valve, mitral valve

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

Thu, 10/09/2014 - 13:27
Auxilium Shareholders to Receive $33.25 Per Share Combination Designed to Create Leading Specialty Healthcare Company with Expanded Platform for Future Growth Addition of Auxilium's Leading Men's Health Products and Development Portfolio Expected to ...
Biopharmaceuticals, Mergers & Acquisitions
Endo International, Auxilium Pharmaceuticals, XIAFLEX

Lombard Medical's Aorfix(TM) Endovascular Stent Graft Adopted by Surgeons at Veteran Affairs Medical Centers

Thu, 10/09/2014 - 13:17
Highlights Value of Uniquely Broad Label for Treating Patients With Abdominal Aortic Aneurysms, Including Those With Complex Anatomies IRVINE, Calif. and LONDON, Oct. 9, 2014 -- (Healthcare Sales & Marketing Network) -- Lombard Medical, Inc. (EVAR), a m...
Devices, Interventional
Lombard Medical, endovascular aneurysm repair, Aorfix , AAA

Cortendo Appoints Robert Lutz as Chief Business Officer

Thu, 10/09/2014 - 13:06
GÖTEBORG, Sweden & RADNOR, Penn.--(Healthcare Sales & Marketing Network)--Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, announced the appointment of Robert Lutz as Chief Business Office...
Biopharmaceuticals, Personnel
Cortendo

EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF Procedure in Controlling GERD Symptoms

Wed, 10/08/2014 - 13:19
Prospective, Randomized Study Showed Durability of Clinical Outcomes in the TIF Group and Improved Control of GERD symptoms in the Crossover Group SAN MATEO, Calif.--(Healthcare Sales & Marketing Network)--EndoGastric Solutions® (EGS), a leader in e...
Devices, Gastroenterology
EndoGastric Solutions, Transoral Incisionless Fundoplication, GERD

Masimo Announces CE Mark of the 11th Rainbow(R) Parameter - ORI(TM), Oxygen Reserve Index(TM)

Wed, 10/08/2014 - 13:11
First Noninvasive & Continuous Parameter to Provide Insight Into Oxygen Reserve in Patients Receiving Supplemental Oxygen NEUCHATEL, SWITZERLAND--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) today announced CE Mark and limited market r...
Devices, Monitoring, Regulatory
Masimo, Oxygen Reserve Index

Kubtec(R) Announces FDA Approval of World’s First Breast Specimen Tomosynthesis System During Breast Cancer Awareness Month

Wed, 10/08/2014 - 13:03
MOZART® with TomoSpec®: 3D Specimen Imaging Technology From Kubtec MILFORD, Conn.--(Healthcare Sales & Marketing Network)--Kubtec, the foremost developer of digital specimen radiography systems, marks the start of Breast Cancer Awareness Month w...
Devices, FDA
Kubtec, MOZART, TomoSpec , tomosynthesis

CardiacAssist Announces the First Human Use of Its PROTEK DUO(TM) Veno-Venous ECLS Kit

Tue, 10/07/2014 - 13:51
Texas man is the world’s first to receive the PROTEK Duo for treatment following surgery PITTSBURGH--(Healthcare Sales & Marketing Network)--CardiacAssist, Inc. today announced that the first PROTEK Duo veno-venous extracorporeal life support (VV ECLS) ...
Devices, Interventional Cardiology
CardiacAssist, PROTEK DUO, extracorporeal life support, TandemHeart

RepliCel Life Sciences Adds Industry Specialist to Management Team

Tue, 10/07/2014 - 13:46
Newly Appointed Vice-President of Business & Corporate Development to Drive External Initiatives VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - RepliCel Life Sciences Inc. (REPCF)(TSX VENTURE:RP), a clinical stage regenerative med...
Regenerative Medicine, Personnel
RepliCel Life Sciences

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)

Tue, 10/07/2014 - 13:38
University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct. 7, 2014 -- (Healthcare Sales & Marketing Network) - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia"...
Biopharmaceuticals, Oncology
Concordia Healthcare, Pinnacle Biologics, PHOTOFRIN, Photodynamic therapy

Miramar Labs Expands Management Team

Tue, 10/07/2014 - 13:22
Miramar Labs Appoints Rob Ellis as VP of Marketing SANTA CLARA, Calif., Oct. 7, 2014 /PRNewswire-iReach/ -- Miramar Labs® Inc., a leading medical device manufacturer and maker of the miraDry® System, today announced the expansion of its manageme...
Devices, Personnel
Miramar Labs, miraDry

Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)

Mon, 10/06/2014 - 15:32
Randomized Controlled SENTINEL Trial is the First in the U.S. to Study Capture and Removal of Debris Released During TAVR That May Otherwise Be the Source of Stroke SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)--Claret Medical, Inc., a deve...
Devices, Interventional Cardiology
Claret Medical, Cerebral Protection, TAVR, transcatheter, aortic valve

bioTheranostics Appoints Nicolas Barthelemy as President and CEO

Mon, 10/06/2014 - 15:28
Industry Veteran to Lead Organization as It Expands Commercialization of Its Molecular Diagnostic Tests for Breast and Metastatic Cancers SAN DIEGO--(Healthcare Sales & Marketing Network)--bioTheranostics, Inc., a leader in molecular diagnostics for can...
Diagnostics, Oncology, Personnel
bioTheranostics, molecular diagnostic, Breast Cancer Index

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong